Artificial Intelligence-assisted Glaucoma Screening (AIAGS)

Overview

This study will develop an artificial intelligence (AI) program for the screening of glaucoma.

We have realized that the glaucomatous optic neuropathy is irreversible. But if early detection and early intervention can be performed to control the development of the disease, it can greatly reduce the blindness rate of glaucoma, improve the life quality and physiological and mental health of patients, and alleviate the social burden. Therefore, screening and early diagnosis of glaucoma is the focus of glaucoma prevention. China has a population of 1.3 billion, which greatly increase the difficulty of disease screening. In recent years, the intersection of artificial intelligence (AI) technology and modern medicine has made efficient and rapid disease screening possible.

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Central Contacts